NanoViricides
NNVC
36 hedge funds and large institutions have $731K invested in NanoViricides in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0.13% less ownership
Funds ownership: 0.33% → 0.2% (-0.13%)
8% less funds holding
Funds holding: 39 → 36 (-3)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
40% less capital invested
Capital invested by funds: $1.23M → $731K (-$495K)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$19.5K |
| 2 |
ACI
Alpha Cubed Investments
Irvine,
California
|
+$3.39K |
| 3 |
BPWA
Beacon Pointe Wealth Advisors
Newport Beach,
California
|
+$3.05K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.78K |
| 5 |
BlackRock
New York
|
+$724 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$368K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$33.1K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$10.2K |
| 4 |
Bank of New York Mellon
New York
|
-$10K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4K |
NNVC Hedge Fund Activity: Q2 2019 in Review
36 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2019, worth a combined $731K — down 40% from $1.23M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NNVC and 1 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $19.5K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $368K sold.
- 36 institutional investors held NanoViricides (NNVC) as of Q2 2019, down from 39 in Q1 2019.
- Funds reported $731K of NanoViricides stock for Q2 2019, down 40% quarter-over-quarter.
- 1 fund opened new NanoViricides positions in Q2 2019 and 4 closed out, a net change of -3 holders.
- The largest NanoViricides buyer in Q2 2019 was Renaissance Technologies, an estimated $19.5K added.
- The largest NanoViricides seller in Q2 2019 was Hudson Bay Capital Management, an estimated $368K sold.
Based on aggregated 13F filings for Q2 2019.